Literature DB >> 12841386

Clonal analysis of granulocyte-monocyte colony-forming unit cells with the human androgen receptor gene in chronic myeloid leukemia.

Salem Akel1, Despina Mavroyanni, Xenophon Yataganas, Evagelos Terpos, John Meletis, Kostas Anargyrou, Niki Stavrogianni, Gerasimos-Alexander Pangalis, Dimitris Loukopoulos, Nora Viniou.   

Abstract

Coexistence of Philadelphia chromosome-negative (Ph-) progenitors with the Ph+ clone in the early chronic phase of chronic myeloid leukemia (CML) has been documented in previous reports. A different evaluation of methods is needed to justify the clonality of the residual Ph- progenitors. Therefore, the X chromosome inactivation patterns in individual granulocyte-monocyte colony-forming unit (CFU-GM) colonies were studied with the clonality assay for the human androgen receptor gene. A prerequisite for this evaluation was the validation of T-lymphocytes and buccal cells as control cells representing the constitutional lyonization. The percentages of polyclonal CFU-GM cells were determined in 9 Ph+ women with CML and in 5 healthy women. Results of the clonal analysis of CFU-GM colonies were compared with those from reverse transcriptase-polymerase chain reaction analysis of single colonies for BCR/ABL transcripts. Both methods of CFU-GM cell analysis were in agreement regarding the presence of variable proportions (0%-94%) of normal cells in CML. Our results suggest that (a) T-cells and buccal cells have potential for use as controls for the clonal analysis of CML cases and (b) this method can evaluate the frequency of polyclonal/clonal CFU-GM cells in CML cases and is applicable to the analysis of myeloid clonal disorders that lack specific molecular markers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841386     DOI: 10.1007/bf02986616

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  26 in total

1.  Spontaneous exodus of high numbers of normal early progenitor cells (Ph-negative LTC-IC) in the peripheral blood of patients with chronic myeloid leukaemia at the beginning of the disease.

Authors:  M Podestà; G Piaggio; M Sessarego; A Pitto; F Benvenuto; F Vassallo; G Fugazza; A M Carella; F Frassoni
Journal:  Br J Haematol       Date:  1997-04       Impact factor: 6.998

2.  BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal.

Authors:  M Delforge; M A Boogaerts; P B McGlave; C M Verfaillie
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

3.  Evaluation at single cell level of residual Philadelphia negative hemopoietic stem cells in chronic phase CML patients.

Authors:  S Akel; A Kolialexi; A Mavrou; C Metaxotou; D Loukopoulos; X Yataganas
Journal:  Cancer Genet Cytogenet       Date:  2000-10-15

Review 4.  Use of genetic markers to study cellular origin and development of tumors in human females.

Authors:  P J Fialkow
Journal:  Adv Cancer Res       Date:  1972       Impact factor: 6.242

5.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

Authors:  B J Druker; M Talpaz; D J Resta; B Peng; E Buchdunger; J M Ford; N B Lydon; H Kantarjian; R Capdeville; S Ohno-Jones; C L Sawyers
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

6.  Tissue specificity of X-chromosome inactivation patterns.

Authors:  R E Gale; H Wheadon; P Boulos; D C Linch
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

7.  Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph1-negative progenitors in treated as well as newly diagnosed patients.

Authors:  I D Dubé; D K Kalousek; L Coulombel; C M Gupta; C J Eaves; A C Eaves
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

8.  Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service.

Authors:  H M Kantarjian; T L Smith; S O'Brien; M Beran; S Pierce; M Talpaz
Journal:  Ann Intern Med       Date:  1995-02-15       Impact factor: 25.391

9.  T lymphocytes lack rearrangement of the bcr gene in Philadelphia chromosome-positive chronic myelocytic leukemia.

Authors:  C R Bartram; A Raghavachar; B Anger; C Stain; P Bettelheim
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

10.  Clonal analysis of peripheral blood and haemopoietic colonies in patients with aplastic anaemia and refractory anaemia using the polymorphic short tandem repeat on the human androgen-receptor (HUMARA) gene.

Authors:  K Anan; M Ito; M Misawa; Y Ohe; S Kai; M Kohsaki; H Hara
Journal:  Br J Haematol       Date:  1995-04       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.